Adam Spielman, Head of Health, Citi Global Insights and Andrew Hopkins, Founder and CEO, Exscientia discuss how AI impacts biopharma, including the extent to which AI is a threat to traditional biopharma companies, and how they should respond.
My Account
Learn more about Global Insights at Citi
Subscribe
Sign up to receive our newsletter providing a roundup of recent content and updates on new reports.
Sign up to receive the latest news from Citi.
